Alzheimer's Disease Trial, Recruiting NCT03665831 Sponsor: Rotman Research Institute at Baycrest Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT03665831
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Alzheimer's disease with mild or major memory and thinking problems, with a certain level of severity confirmed by a rating scale (confirm with trial site)
  • You have been diagnosed with major depression, and your current episode of depression has lasted more than 4 weeks but less than 5 years
  • You tried antidepressant medication but it either did not work for you or you could not tolerate it
  • You are willing and able to give your consent to participate in the study
  • You are able to follow the treatment schedule as required by the trial
  • If you take medications, your doses have been stable for at least 2 months and are not expected to change during the study
  • You have passed a safety screening questionnaire related to the brain stimulation treatment used in this trial (confirm with trial site)
  • You have a family member, friend, or caregiver who can fill out questionnaires about you during the study

Who may not be able to join:

  • You have any metal implants in your head, such as ear implants, brain stimulators, or aneurysm clips (metal dental work in the mouth is generally okay — confirm with trial site)
  • You have or have had increased pressure in your brain, which may raise the risk of seizures
  • You have a cardiac pacemaker
  • You have an implanted medication pump inside your body
  • You have a central venous line (a tube inserted into a large vein — confirm with trial site)
  • You have a significant heart condition or a history of stroke
  • Your memory loss is thought to be significantly related to blood vessel problems in the brain (confirm with trial site)
  • You have a history of psychosis, bipolar disorder, an eating disorder, OCD, PTSD, or a type of dementia other than Alzheimer's
  • You have used alcohol or drugs in a harmful way within the last 6 months
  • You have a history of stroke or other damage or abnormalities in your brain
  • You have a personal history of epilepsy or seizures
  • You have a family history of epilepsy or seizures
  • You are currently pregnant or breastfeeding
  • You are currently taking certain psychiatric medications, including antidepressants, antipsychotics, or mood stabilisers, due to an increased risk of seizures
  • You are currently taking the medication memantine
  • You have had an abnormal brain MRI (brain scan) in the past
  • You have significant hearing loss that requires you to use hearing aids
  • You have an untreated thyroid condition (either underactive or overactive thyroid)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-785-2500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Rotman Research Institute at Baycrest
Registry
ClinicalTrials.gov
Start date
23 October 2018
Est. completion
15 August 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change From Baseline on the Montgomery-Asberg Depression Rating Scale (MADRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov